טוען...
Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection
New therapies against hepatitis B virus (HBV) require the elimination of covalently closed circular DNA (cccDNA), the episomal HBV genome. HBV plasmids containing an overlength 1.3-mer genome and bacterial backbone (pHBV1.3) are used in many different models, but do not replicate the unique features...
שמור ב:
| הוצא לאור ב: | Virus Res |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779077/ https://ncbi.nlm.nih.gov/pubmed/33166564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virusres.2020.198224 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|